Certified by Founder Lodge
Tribune Therapeutics
Norway - Oslo
START UP
1 Disclosed Funding Rounds $39,883,965
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 27 ,2025 | Seed | $39,883,965 |
LifeArc Ventures
HealthCap
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Manifold Security | $8,000,000 | (Mar 19, 2026)
Homaio | $4,135,744 | (Mar 19, 2026)
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
